Summary & Overview
CPT 89322: Comprehensive Semen Analysis with Morphologic Criteria
CPT code 89322 represents a comprehensive laboratory analysis of a semen specimen, focusing on volume, sperm count, motility, and white blood cell differential using strict morphologic criteria. This procedure is a cornerstone in the evaluation of male infertility and is widely utilized in clinical settings to inform fertility treatment decisions. The code is recognized by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, ensuring broad coverage for patients seeking fertility assessment.
This publication provides an in-depth overview of 89322, including payer coverage, clinical context, and related laboratory procedures. Readers will gain insight into the benchmarks for laboratory billing, recent policy updates affecting reimbursement, and the role of this test in the broader landscape of reproductive health. The analysis also highlights associated diagnoses such as male infertility and encounter for fertility testing, offering a comprehensive perspective for stakeholders in laboratory medicine, clinical pathology, and reproductive health.
Key sections include payer coverage details, clinical indications, and comparisons to related CPT codes. The publication is designed for laboratory administrators, clinicians, and healthcare policy professionals seeking clarity on coding, coverage, and clinical relevance of semen analysis procedures.
CPT Code Overview
CPT code 89322 is used to report a laboratory procedure in which a semen specimen is analyzed for volume, sperm count, motility, and differential of white blood cells, all assessed using strict morphologic criteria. This test provides detailed information about the form and appearance of sperm and other cells in the sample, which is essential for evaluating male fertility. The service type is Laboratory, and the typical site of service is a laboratory facility (Place of Service 81).
Clinical & Coding Specifications
Clinical Context
A male patient presents to a fertility clinic or urology practice with concerns about infertility. The provider orders a comprehensive semen analysis to evaluate sperm volume, count, motility, and morphology, as well as to assess the presence and differential of white blood cells. The specimen is collected and sent to a laboratory (Place of Service 81) where a lab analyst performs the technical test using strict morphologic criteria. The results assist the provider in diagnosing conditions such as azoospermia, oligospermia, or other forms of male infertility, and guide further management or fertility counseling.
Coding Specifications
-
Modifiers:
26- Professional Component: Used when only the interpretation of the laboratory test is performed by the physician or pathologist.TC- Technical Component: Used when only the technical aspect of the laboratory test (e.g., specimen processing and analysis) is performed.
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
207ZC0000X | Clinical Pathology/Laboratory Medicine |
207V00000X | Obstetrics & Gynecology Physician |
207Q00000X | Family Medicine Physician |
These taxonomies represent providers who may order or interpret the semen analysis, including laboratory medicine specialists, OB/GYNs, and family medicine physicians.
Related Diagnoses
-
N46.9- Male infertility, unspecified- Used when the patient is diagnosed with infertility but the specific cause is not determined. Relevant for ordering semen analysis to investigate underlying factors.
-
Z31.41- Encounter for fertility testing- Indicates the visit is specifically for fertility evaluation. Supports medical necessity for semen analysis.
-
N46.01- Azoospermia- Refers to absence of sperm in the semen. Semen analysis is essential for diagnosing this condition.
-
N46.11- Oligospermia- Indicates low sperm count. Semen analysis quantifies sperm concentration and is used to confirm this diagnosis.
-
N46.8- Other male infertility- Covers other specified causes of male infertility. Semen analysis helps identify or rule out these conditions.
Related CPT Codes
-
89320- Semen analysis; presence and/or motility of sperm- Used for basic assessment of sperm presence and motility. May be ordered as an initial screening or in less comprehensive evaluations.
-
89321- Semen analysis; sperm presence and motility of sperm, complete- Provides a more complete analysis than
89320, including additional parameters. Can be used as an alternative or in conjunction with89322depending on clinical needs.
- Provides a more complete analysis than
-
89325- Sperm antibodies test- Assesses for antibodies against sperm, which may contribute to infertility. Often ordered alongside
89322in infertility workups.
- Assesses for antibodies against sperm, which may contribute to infertility. Often ordered alongside
-
89329- Sperm evaluation; cervical mucus penetration test- Evaluates sperm's ability to penetrate cervical mucus, relevant in infertility investigations. May be used in combination with
89322for comprehensive assessment.
- Evaluates sperm's ability to penetrate cervical mucus, relevant in infertility investigations. May be used in combination with
These codes are related to the primary CPT code 89322 and may be used together or as alternatives depending on the clinical scenario and depth of analysis required.
National Reimbursement Benchmarks
For CPT code 89322, the national mean rate for BUCA (average commercial) payers is $16.70, which is higher than the typical Medicare rate for similar codes, though Medicare data is not available in the input for direct comparison. Among individual commercial payers, Cigna has the highest mean rate at $18.60, while UnitedHealth Group is the lowest at $15.80.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Cigna shows the widest spread at $12.00 ($21.00 - $9.00), indicating greater variability in contracted rates. Aetna and BUCA have tighter ranges of $6.00 and $7.00, respectively, suggesting more consistent rates across providers. Blue Cross Blue Shield and UnitedHealth Group both have moderate dispersion, with ranges of $7.81 and $8.00.
The table and chart below present the full breakdown of national benchmarks for each payer, including mean rates and percentile values.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.